Therapies
The Science
About us
Investors
News

Hit enter to search or ESC to close

Prana – ANA Abstract Submission NLP

October 17, 2016 Kerry Rowe

final-ana-abstract-submission-nlp-4-8-16

Post navigation

New data from Reach2HD trial presented at American Neurological Association Annual Meeting

Related Posts

Prana commences US Investor Roadshow

January 23, 2014

Prana AGM Investor Conference Call

November 10, 2017

Prana Alzheimer’s disease Development Plan Update

July 17, 2014

Recent Posts

Alterity Therapeutics commences US investor meetings following positive clinical data
Alterity Therapeutics AAN Presentation 5 May 2019
Initial data for Alterity Therapeutics Phase 1 clinical trial released at American Academy of Neurology Annual Meeting
Alterity Therapeutics presents at the American Academy of Neurology Annual Meeting
Alterity Therapeutics Investor Presentation

Recent Comments

Archives

Archives

Categories

Investor Announcement

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

Therapies
The Science
About us
Investors
News
Contact us

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065